Best Healthcare Technology Stocks To Watch For 2015

After finishing 2013 up more than 26 percent, the Dow and other major US stock indexes have been on a rollercoaster ride to start 2014. What�� causing the swings? Is the volatility justified?

In a new podcast, Ron Joelson, executive vice president and chief investment officer, Northwestern Mutual, and Mark McLennon, vice president of investment advisory services, Northwestern Mutual Wealth Management Company, share their perspectives on the topic and others that are getting national attention.

Joelson believes that in 2013 there was likely an over-reaction as we came out of the recession. Now, in 2014, he doesn�� believe solid economic fundamentals alone are enough to move the market. Hear Joelson and McLennon�� thoughts in Northwestern Mutual Perspectives:

The Northwestern MutualVoice Team is a group of professionals who share insights and opinions from experts and industry leaders across the enterprise. Our vision is to inspire others to take action and plan for their financial future through topics ranging from financial planning, retirement planning and distribution strategies, wealth accumulation and preservation, to leadership, philanthropy and innovation. 

Best Healthcare Technology Stocks To Watch For 2015: Twin Butte Energy Ltd (TBTEF.PK)

Twin Butte Energy Ltd. (Twin Butte) is a Canada-based junior oil and gas exploration and production company. The Company is engaged in the acquisition of, exploration for and the development and production of petroleum and natural gas properties in Western Canada. During the year ended December 31, 2011, it drilled a total of 125 (80.9 net) wells. Its Frog Lake property is located approximately 75 kilometers northwest of Lloydminster with lands. Its Freemont area is located 60 kilometers southeast of Lloydminster. During 2011, Twin Butte drilled 11 gross wells in Plains region. Production from its west central Alberta region was approximately 1,545 barrels of oil equivalent per day during 2011. Production from its Deep Basin region was approximately 593 barrels of oil equivalent per day during 2011. Effective September 30, 2013, the Company disposed a non-core, west central Alberta, gas asset. In November 2013, the Company acquired Black Shire Energy Inc. Advisors' Opinion:

• [By MLP Trader]

  Here are the current top five companies in the list:

  CompanySymbolEV/BOEPD/NetbackPrice/NAVEV/DACFPinecrest(PNCGF.PK)53564%4.0XLightstream(LSTMF.PK)131753%4.5XNovus(NOVUF.PK)133290%4.1XZargon(ZARFF.PK)138664%5.6XTwin Butte(TBTEF.PK)155885%5.5X

  Of the larger companies, one that remains obstinately near the top of the list is Lightstream . Lightstream trades at 40% of its book value and a whopping 13.4% yield.

Best Healthcare Technology Stocks To Watch For 2015: Pluristem Therapeutics Inc.(PSTI)

Pluristem Therapeutics Inc., a bio-therapeutic company, engages in the research, development, and commercialization of standardized cell therapy products for the treatment of life threatening diseases. The company?s products are derived from human placenta, a non-controversial, non-embryonic, adult cell source. Its Placental adherent stromal cells are grown in the company's proprietary PluriX three-dimensional process that allows cells to grow in a natural environment. The company provides PLX-PAD that has completed Phase I clinical trials for people suffering from peripheral artery disease. It also offers various product candidates for diabetic foot ulcers, adjuvant hip replacement surgery, athletic injuries, inflammatory bowel disease, multiple sclerosis, neuropathic pain, ischemic stroke, adjuvant for UCB transplantation, and radiation exposure. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is headquartered in Haifa, Israel.

Advisors' Opinion:

• [By John Udovich]

  Stem cell stocks have not exactly been the best performers lately in part because the controversy over their use has died down over the years while major breakthroughs have been few or far between, but the industry along with small cap stem cell stocks Pluristem Therapeutics Inc (NASDAQ: PSTI), BioTime, Inc (NYSEMKT: BTX) and BioRestorative Therapies (OTCBB: BRTX) are still quietly producing their share of news or minor breakthroughs worth taking note of. Just consider the following stem cell news or news from small cap players in the sector:

• [By James E. Brumley]

  Traders may not want to get married for the long haul to any of them, but for speculators looking for a quick, profitable hit, Arca Biopharma Inc. (NASDAQ:ABIO), Pluristem Therapeutics Inc. (NASDAQ:PSTI), and Bacterin International Holdings Inc. (NYSEMKT:BONE) may be better-than-average bets. Here's why.

Top 10 Construction Stocks To Invest In 2015: Saes Getters SpA (SG&A)

SAES Getters SpA is an Italy-based company primarily engaged in the production of getters and metal dispensers. The Company structures its business into three main units: Industrial Applications, which includes getters and metal dispensers used in light sources and electron vacuum devices, getters for microelectronic and micromechanical systems, pumps for vacuum systems, getters for solar collectors, products for thermal insulation, and gas purifier systems; Shape Memory Alloys, which includes shape memory alloy semi-finished products, components and devices for medical and industrial applications, and Information Displays, which includes getters and metal dispensers for liquid crystal displays, and barium getters for cathode ray tubes. Additionally, through the Business Development Unit, the Company produces dryers and getters for organic light-emitting diode (OLED), sealants for solar panels and energy storage getter devices. Advisors' Opinion:

• [By Jason Rivera]

  To help facilitate this destruction of value has been that Koss has bought back a lot of its shares as the company has been overvalued. The below quote is from its most recent annual report.
  In April of 1995, the Board of Directors approved a stock repurchase program authorizing the Company to purchase from time to time up to $2,000,000 of its common stock for its own account. Subsequently, the Board of Directors periodically has approved increases in the stock repurchase program. As of June 30, 2012, the most recently approved increase was for additional purchases of $2,000,000, which occurred in October of 2006, for an aggregate maximum of $45,500,000, of which $43,360,247 had been expended through June 30, 2012 . No purchases were made during the year ended June 30, 2012. The Company intends to effect all stock purchases either on the open market or through privately negotiated transactions and intends to finance all stock purchases through its own cash flow or by borrowing for such purchases.As you can see from this page, most of KOSS' margins have dropped substantially since 2007. Especially of note is its operating margin, ROE and ROIC. Book value per share, cash flow per share, revenue and working capital have all dropped substantially as well. Normally when I have evaluated companies' cost of goods sold rising is what has caused the above metrics to drop, but that has stayed relatively stable over the years at KOSS. The culprit in this case is selling, general and administrative (SG&A) related expenses expressed below as a percentage of its sales. The following numbers were taken from Morningstar:

• [By GURUFOCUS]

  For investors, Qualcomm understand the benefits of cloud services. It seems there are numerous questions unresolved. Over the last decade, pharmaceutical companies have been aggregating years of research and development data into medical databases, initiating overhauls of its R&D and selling, general and administrative (SG&A) segments for Pharma. A company willing to build their capabilities, and open to a new view of value will likely achieve better outcomes. Delivering support, personalization, scalability, speed and flexibility are attractive areas for growth.

Best Healthcare Technology Stocks To Watch For 2015: Grupo Casa Saba S.A. de C.V.(SAB)

Grupo Casa Saba, S.A.B. de C.V., through its subsidiaries, operates as a multi-channel and multi-product wholesale distributor primarily in Mexico. It distributes pharmaceutical products; health and beauty aids; publication products, such as magazines, books, albums, and stickers; food and non-perishable products; personal care and consumer goods; and general merchandise. The company also sells pharmaceutical products through its Farmacias ABC pharmacy chain located in Guadalajara, Jalisco; Farmacias Provee de Especialidades primarily located in Monterrey and Nuevo Leon of Mexico, as well as in the states of Chihuahua and Coahuila; and through Farmacias Benavides. In addition, it provides freight services to third parties. Further, it operates medical clinics; and offers specialized medical, rehabilitation, and surgical services, as well as provides real estate services. The company serves pharmacies, mass merchandisers, retail and convenience stores, specialty stores, sup ermarkets, and other specialized channels. As of December 31, 2010, it operated a distribution network consisting of 22 active distribution centers. It also operates in Brazil, Chile, and Peru. Grupo Casa Saba, S.A.B. de C.V. was founded in 1892 and is based in Mexico, Mexico.

Advisors' Opinion:

• [By Tom Stoukas]

  SABMiller Plc (SAB) lost 2.1 percent to 3,462 pence. The world�� second-largest brewer said earnings before interest, taxes and amortization in the year to March 31 rose to $6.42 billion. That missed the median estimate of 13 analysts in a Bloomberg News survey that called for $6.46 billion.

• [By Sofia Horta e Costa]

  SABMiller Plc (SAB), the world�� second-biggest brewer, dropped 2.1 percent to 3,165 pence. Credit Suisse Group AG cut its rating on the beverage industry to benchmark, similar to neutral, from overweight, citing valuations. The Stoxx 600 Food & Beverage Index trades at 18.2 times projected earnings, compared with 14.3 times profit for the broader gauge, according to data compiled by Bloomberg.

• [By Inyoung Hwang]

  U.K. stocks erased losses in the last half hour of trading, leaving the FTSE 100 Index (UKX) little changed, as a rally in British Sky Broadcasting Group Plc (BSY) and SABMiller Plc (SAB) offset Dagong Global Credit Rating Co.�� downgrade of U.S. sovereign debt.

Best Healthcare Technology Stocks To Watch For 2015: Wolverine World Wide Inc.(WWW)

Wolverine World Wide, Inc. designs, manufactures, sources, markets, licenses, and distributes branded footwear, apparel, and accessories. It offers industrial work shoes, boots, uniform shoes, outdoor sports footwear, rugged casual footwear, lifestyle footwear, sandals, and closed-toe products. It also provides outdoor apparel, and work and rugged casual apparel; and accessories, such as packs, bags, and luggage, as well as eyewear, gloves, handbags, socks, watches, and plush toys. The company offers its products under various brand names, including Bates, Cat Footwear, Chaco, Cushe, Harley-Davidson Footwear, Hush Puppies, HyTest, Merrell, Patagonia Footwear, Sebago, Soft Style, and Wolverine. It sells its products to a range of retail customers, which comprise department stores, national chains, catalogs, specialty retailers, mass merchants, Internet retailers, governments, and municipalities in the United States, Canada, and Europe. The company also markets its products in approximately 190 countries and territories through company-owned wholesale operations, licensees, and distributors. It also licenses its brands for use on non-footwear products. As of December 31, 2011, the company operated 101 retail stores in the United States, Canada, and the United Kingdom; and operated 42 consumer-direct Websites. Further, it markets pigskin leather, and purchases raw pigskins from other source. Wolverine World Wide, Inc. was founded in 1883 and is based in Rockford, Michigan.

Advisors' Opinion:

• [By Michael Lewis]

  Two of the biggest shoe companies available to investors, Deckers Outdoor (NASDAQ: DECK  ) and Wolverine Worldwide (NYSE: WWW  ) , have experienced great growth in recent periods, with the former posting a 20% stock gain on the day it released earnings last week. Both companies have made fantastic accretive brand purchases and renovations over the past year, and both should continue to grow at appealing rates. Unfortunately for investors, both also appear to be fully valued stocks. The question for investors going forward regards whether the companies' phenomenal successes can sustain the lofty valuations imparted by an ever-myopic market.

• [By Dan Moskowitz]

  Skechers (NYSE: SKX  ) has is up 65% year-to-date, outperforming Brown Shoe (NYSE: BWS  ) , Wolverine World Wide (NYSE: WWW  ) , Deckers Outdoor (NASDAQ: DECK  ) , and Nike (NYSE: NKE  ) , which have appreciated 26%, 39%, 62%, and 43%, respectively. Skechers' upside move is justifiable based on the company's recent performance. At the same time, this doesn't mean Skechers will offer the best long-term investment opportunity in this group.

Best Healthcare Technology Stocks To Watch For 2015: Central Europe Russia and Turkey Fund Inc (CEE)

Central Europe and Russia Fund, Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund seeks long-term capital appreciation primarily through investment in equity and equity-linked securities of issuers domiciled in Central Europe and Russia. The Fund's portfolio includes investments in Russian, Polish, Hungarian, Czech Republic, Turkish, Austrian, Dutch, Cyprus, Bermuda and Virgin Islands common stocks.

The Fund invests in various industries, including commercial banks, diversified telecommunication services, food products, metals and mining, personal products, wireless telecommunication services, building products, construction and engineering, diversified telecommunication services, media, pharmaceuticals, automobiles, and oil, gas and consumable fuels. The Fund is managed and advised by subsidiaries of the Deutsche Bank Group. The Fund's investment advisor is Deutsche Asset Management International GmbH. The Fund's manager is Deutsche Investment Management Americas Inc.

Advisors' Opinion:

• [By STANSBERRYRESEARCH]

  
  With emerging market speculation heating up again, TRF is trading for a 24% premium right now. If that premium climbs any higher, we predict another obliteration. – Brian Hunt, DailyWealth, December 21, 2006

  
  We published that note in December 2006. By March 2009, it had lost more than 90% of its value.   Perhaps more importantly to any long-term, buy-and-hold investor, the decline we foresaw in the fund would have wiped out more than 100% of the accumulated capital gains, assuming you invested as much as 15 years earlier.   Now... I'd like you to look at the chart one more time. Look at what happened to the fund in the first half of 2009. It went nearly straight up.   On April 17, 2009, we told subscribers to buy Russian stocks. Instead of using TRF, Steve Sjuggerud recommended a nearly identical Scudder Fund, the Central Europe and Russia Fund (NYSE: CEE). Both went up 150% from their March lows.   So if you followed the buy-and-hold strategy in Russian stocks over the last 15 years, you would have made a very small amount of money – or lost money, depending on when you sold your shares. On the other hand, if you applied a few of our secrets, you could have easily traded this fund for more than 100% gains in only a few weeks. And if you watch this fund, you'll be able to make trades like this three or four times each decade. If you watch other similar funds, you'll be able to make trades like this once or twice a year.   And let me tell you one more thing about this situation. In January 2007, when TRF was widely overvalued and when most individual investors were clamoring to buy shares – despite the premium valuation – we checked to see if we could sell the fund short. We knew it was going to collapse and wanted to profit directly as it fell. But we couldn't. Why not? Because other professionals had already borrowed all of the available shares to sh

Best Healthcare Technology Stocks To Watch For 2015: LTX-Credence Corporation(LTXC)

LTX-Credence Corporation designs, manufactures, markets, and services automated test equipment solutions for the wireless, computing, automotive, and consumer markets. The company?s product portfolio includes Diamond platform, a package for testing microcontrollers and cost sensitive consumer devices; X-Series platform that offers configurations for optimal testing of ASSP and ASIC, power, automotive, mixed signal, and RF applications; and ASL platform, which is used for testing linear, low-end mixed signal, precision analog, and power management devices. The company also provides various services, including installation and maintenance of test systems, servicing of spare parts, parts and labor warranties on test systems, and training on the maintenance and operation of test systems. LTX-Credence Corporation sells its products through direct sales organization and distributors in the United States, Taiwan, China, Japan, Korea, and southeast Asia. The company was founded i n 1976 and is headquartered in Norwood, Massachusetts.

Advisors' Opinion:

• [By CRWE]

  LTX-Credence Corporation (Nasdaq:LTXC), a global provider of market focused, cost-optimized ATE solutions, reported that it will present at the Barclays Capital Global Technology, Media and Telecommunications Conference on Wednesday, May 23, 2012 at 4:15 PM EDT. This event will be available over the Internet via live webcast.

Best Healthcare Technology Stocks To Watch For 2015: Legal & General Group PLC (LGEN)

Legal & General Group Plc is a provider of risk, savings and investment management products in the United Kingdom. The Company's operating segments include Protection and Annuities segment consisting of individual and group protection, individual and bulk purchase annuities, longevity and general insurance; Savings segment consisting of non-profit investment bonds, non-profit pensions (including self-invested personal pensions (SIPPs)), individual savings account (ISAs), retail unit trusts and retail platform businesses; Investment management segment consisting of institutional fund management and LGIM America (LGIMA); US Protection segment consisting of individual protection and universal life contracts, and Group capital and financing consists of shareholders��equity supporting the non profit Protection and Annuities and Savings businesses. In August 2013, Legal & General Group Plc announced the acquisition of Lucida Limited. Advisors' Opinion:

• [By Rupert Hargreaves]

  Unfortunately, Prudential only offers a dividend yield of 2.4% at present, below that of its peers, such as Aviva (AV) and Legal & General (LGEN). Moreover, city analysts only expect Prudential to increase its payout by 10% this year and 5% during 2014.

Best Healthcare Technology Stocks To Watch For 2015: News Corporation(NWS)

News Corporation operates as a diversified media company worldwide. Its Cable Network Programming segment produces and licenses news, business news, sports, general entertainment, and movie programming for distribution through cable television systems and direct broadcast satellite operators primarily in the United States, Latin America, Europe, and Asia. The company?s Filmed Entertainment segment produces and acquires live-action and animated motion pictures for distribution and licensing in entertainment media, as well as produces and licenses television programming worldwide. Its Television segment operates 27 broadcast television stations in the United States. The company?s Direct Broadcast Satellite Television segment distributes programming services via satellite and broadband directly to subscribers in Italy. Its Publishing segment provides newspapers and information services, such as publishing national newspapers in the United Kingdom, approximately 146 newspape rs in Australia, and a metropolitan and a national newspaper in the United States; book publishing services, including the publishing of English language books worldwide; and integrated marketing services comprising the publishing of free-standing inserts, which are marketing booklets containing coupons, rebates, and other consumer offers, as well as provides in-store marketing products and services, primarily to consumer packaged goods manufacturers in the United States and Canada. The company also sells advertising, sponsorships, and subscription services on the company?s various digital media properties and outdoor advertising space on various media primarily in Russia and eastern Europe; and provides data systems and professional services that enable teachers to use data to assess student progress and deliver individualized instructions. News Corporation was founded in 1922 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Julianne Pepitone]

  The Times isn't the only newspaper to lose its star tech columnist recently. Last month, news broke that Walt Mossberg will leave his post covering consumer tech at Wall Street Journal. The move comes after the newspaper's parent company News Corp. (NWS) did not renew its contract with AllThingsD, the tech site that Mossberg co-created with Kara Swisher.

• [By Sue Chang and Saumya Vaishampayan]

  News Corp (NWS) � (NWSA) �added 8.4%. The media company said late Thursday its fiscal second-quarter profit slid to $150 million, or 26 cents a share, from $1.4 billion, or $2.42 a share, a year ago. Last year�� earnings were affected by a $1.3 billion gain from an acquisition. But on an adjusted basis, it earned 31 cents a share, ahead of the 21-cent profit forecast by analysts. News Corp is the parent of MarketWatch, the publisher of this report.

Best Healthcare Technology Stocks To Watch For 2015: Halcon Resources Corp (HK)

Halcon Resources Corporation (Halcon Resources), incorporated on February 5, 2004, is an independent energy company focused on the acquisition, production, exploration and development of onshore liquids-rich oil and natural gas assets in the United States. The Company has oil and natural gas reserves located primarily in Texas, North Dakota, Louisiana, Oklahoma and Montana. On August 1, 2012, the Company acquired GeoResources by merger. On December 6, 2012, the Company completed the acquisition of entities owning approximately 81,000 net acres prospective for the Bakken / Three Forks formations primarily located in Williams, Mountrail, McKenzie and Dunn Counties, North Dakota (the Williston Basin Assets), from Petro-Hunt, L.L.C. and Pillar Energy, LLC (the Petro-Hunt parties). As of December 31, 2012, the Company has working interests in approximately 128,000 net acres prospective for the Bakken / Three Forks formations in North Dakota and Montana.

The Company�� Woodbine / Eagle Ford acreage is prospective for the Woodbine, Eagle Ford and other formations, with targeted depths ranging anywhere from 7,000 feet to 10,400 feet. As of December 31, 2012, The Company has approximately 198,000 net acres leased or under contract primarily in Leon, Madison, Grimes, Brazos, and Polk Counties, Texas. The Company is the operator and has a 100% working interest in more than 12,000 net acres in Wichita and Wilbarger Counties, Texas that it is actively water flooding in shallow Cisco aged Pennsylvania sandstone and limestone reservoirs. As of December 31, 2012, the Company produced 484 million barrels of oil equivalent from approximately 700 active producing wells and approximately 230 active water injection wells.

The Company�� position in the La Copita Field covers 3,720 gross acres and 2,829 net acres in Starr County, Texas. As of December 31, 2012, the Company�� average net daily production was 623 barrels of oil equivalent per day. The Company operates 100% of this production a! nd its working interest ranges from 75% to 100%. The Company has various other oil and natural gas properties with varying working interests located across the United States, including the Austin Chalk Trend and Eagle Ford Shale in Texas, the Fitts-Allen Fields in Central Oklahoma, and various other areas across South Louisiana, Montana, North Dakota, New Mexico, and West Virginia.

Advisors' Opinion:

• [By David Sterman]

   

  2. Halcon Resources (NYSE: HK) Insiders bought more than $2 million of this energy exploration firm in early August as part of a secondary share offering priced at $5.10 a share. In the past 10 days, as shares have slipped below the $5 mark, insiders have continued to accumulate shares.

  Halcon has a legion of fans in the financial blogosphere, and this recent post typifies the bullish sentiment of some.

• [By Matt DiLallo]

  Last week at its Analyst Day Chesapeake Energy (NYSE: CHK  ) unveiled the Utica Shale as its next world-class asset. That's in stark contrast to what Halcon Resources (NYSE: HK  ) thinks about the play, as it has virtually abandoned its efforts to develop its Utica Shale acreage. It's divergent opinions like these that make it tough for investors to determine who to believe when it comes to the Utica Shale.